ArticleBMC cancer2025

Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.

Mehmet Ali Nahit Sendur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.